Verona Pharma (VRNA) News Today $58.47 +0.66 (+1.14%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$58.07 -0.40 (-0.68%) As of 04/15/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate UpdateApril 15 at 7:22 PM | markets.businessinsider.comRaymond James Financial Inc. Buys New Shares in Verona Pharma plc (NASDAQ:VRNA)Raymond James Financial Inc. purchased a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,855 shares of the company's stock, valued at approximatelyApril 14 at 3:04 AM | marketbeat.comKennedy Capital Management LLC Sells 12,344 Shares of Verona Pharma plc (NASDAQ:VRNA)Kennedy Capital Management LLC cut its position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 346,103 shares of the company's stock after seApril 12, 2025 | marketbeat.comTrexquant Investment LP Takes Position in Verona Pharma plc (NASDAQ:VRNA)Trexquant Investment LP bought a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 31,162 shares of the company's stock, valued atApril 12, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Shares Down 11.3% - What's Next?Verona Pharma (NASDAQ:VRNA) Shares Down 11.3% - What's Next?April 9, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Bought by ADAR1 Capital Management LLCADAR1 Capital Management LLC increased its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 191.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,100 shares of the company's stockApril 9, 2025 | marketbeat.comFederated Hermes Inc. Has $84.77 Million Position in Verona Pharma plc (NASDAQ:VRNA)Federated Hermes Inc. cut its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 15.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,825,293 shares of the company's stock after selling 342,607 shares durApril 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Takes Position in Verona Pharma plc (NASDAQ:VRNA)Springhill Fund Asset Management HK Co Ltd acquired a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 135,452 shareApril 8, 2025 | marketbeat.comAtika Capital Management LLC Boosts Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Atika Capital Management LLC raised its position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 194.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 212,000 shares of the company's stock aftApril 8, 2025 | marketbeat.comVerona Pharma's Bull Case Holds, But Lifecycle Extension Is CriticalApril 7, 2025 | seekingalpha.comFranklin Resources Inc. Raises Position in Verona Pharma plc (NASDAQ:VRNA)Franklin Resources Inc. boosted its stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 41.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 791,104 shares of the company's stock after buying an additional 231,376 shares during the perioApril 7, 2025 | marketbeat.comWellington Management Group LLP Buys 1,146,609 Shares of Verona Pharma plc (NASDAQ:VRNA)Wellington Management Group LLP increased its stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 61.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,025,241 shares of the company's sApril 5, 2025 | marketbeat.comSei Investments Co. Lowers Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Sei Investments Co. lowered its position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,777 shares of the company'sApril 5, 2025 | marketbeat.comClearbridge Investments LLC Decreases Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Clearbridge Investments LLC lowered its position in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 23.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 312,173 shares of the company's stock after sellingApril 4, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Shares Down 7% - Should You Sell?Verona Pharma (NASDAQ:VRNA) Trading Down 7% - What's Next?April 3, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Sold by Knott David M JrKnott David M Jr cut its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 11.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 159,300 shares of the company's stock after selling 20,700 shares duringApril 2, 2025 | marketbeat.comVerona Pharma Options Trading: A Deep Dive into Market SentimentMarch 30, 2025 | nasdaq.comVerona Pharma plc (NASDAQ:VRNA) Shares Bought by Prudential Financial Inc.Prudential Financial Inc. grew its position in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 17.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 208,100 shares of the company's stock after purchasingMarch 30, 2025 | marketbeat.comAmerican Century Companies Inc. Has $28.78 Million Stock Position in Verona Pharma plc (NASDAQ:VRNA)American Century Companies Inc. lessened its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 29.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 619,805 shares of the company's stock after selling 256,7March 30, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Sold by Loomis Sayles & Co. L PLoomis Sayles & Co. L P reduced its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,079,555 shares of the company's stock afterMarch 29, 2025 | marketbeat.comVerona Pharma plc: Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERSMarch 28, 2025 | finanznachrichten.de4VRNA : Verona Pharma Options Trading: A Deep Dive into Market SentimentMarch 28, 2025 | benzinga.comVerona Pharma Announces Amended Strategic Financing with Oaktree and OMERSMarch 28, 2025 | globenewswire.comVerona Pharma plc (NASDAQ:VRNA) Shares Sold by BIT Capital GmbHBIT Capital GmbH cut its position in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 86.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,830 shares of the company's stock after selling 199,373 sharesMarch 28, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Given Consensus Rating of "Buy" by BrokeragesVerona Pharma plc (NASDAQ:VRNA - Get Free Report) has been given a consensus rating of "Buy" by the seven ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation tMarch 27, 2025 | marketbeat.comJim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”March 26, 2025 | insidermonkey.comVerona Pharma (NASDAQ:VRNA) Shares Down 2% - Should You Sell?Verona Pharma (NASDAQ:VRNA) Stock Price Down 2% - What's Next?March 25, 2025 | marketbeat.comRosalind Advisors Inc. Has $6.97 Million Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Rosalind Advisors Inc. reduced its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 45.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 150,000 shares of the company's stock after selling 125,March 23, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Purchased by EverSource Wealth Advisors LLCEverSource Wealth Advisors LLC raised its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 3,074.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,158 shares of the company's stock afMarch 16, 2025 | marketbeat.comM&T Bank Corp Makes New $243,000 Investment in Verona Pharma plc (NASDAQ:VRNA)M&T Bank Corp bought a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 5,243 shares of the company's stock, valued at approximately $243,000.March 16, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Shares Gap Down on Insider SellingVerona Pharma (NASDAQ:VRNA) Shares Gap Down After Insider SellingMarch 15, 2025 | marketbeat.comHBK Sorce Advisory LLC Increases Position in Verona Pharma plc (NASDAQ:VRNA)HBK Sorce Advisory LLC increased its stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 387.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,814 shares of the company's stock after buyingMarch 15, 2025 | marketbeat.comAtria Investments Inc Has $642,000 Holdings in Verona Pharma plc (NASDAQ:VRNA)Atria Investments Inc trimmed its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 27.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,833 shares of the company's stockMarch 15, 2025 | marketbeat.comKathleen A. Rickard Sells 79,264 Shares of Verona Pharma plc (NASDAQ:VRNA) StockVerona Pharma plc (NASDAQ:VRNA - Get Free Report) insider Kathleen A. Rickard sold 79,264 shares of the company's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $8.35, for a total value of $661,854.40. Following the completion of the sale, the insider now owns 2,608,976 shares in the company, valued at approximately $21,784,949.60. This represents a 2.95 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 14, 2025 | marketbeat.comIs Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?March 14, 2025 | msn.comVerona Pharma: Great Year For Share Price, But Competition Threatens Bull ThesisMarch 13, 2025 | seekingalpha.comVerona Pharma (NASDAQ:VRNA) Trading Up 5.8% - Should You Buy?Verona Pharma (NASDAQ:VRNA) Trading Up 5.8% - Time to Buy?March 13, 2025 | marketbeat.comUS Bancorp DE Has $401,000 Stake in Verona Pharma plc (NASDAQ:VRNA)US Bancorp DE decreased its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 60.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,627 shares of the company's stock after selling 13,328 shares durMarch 13, 2025 | marketbeat.comPersonal CFO Solutions LLC Makes New $284,000 Investment in Verona Pharma plc (NASDAQ:VRNA)Personal CFO Solutions LLC bought a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 6,109 shares of the company's stock, valued at approximately $284,000. SeMarch 11, 2025 | marketbeat.comKeybank National Association OH Acquires Shares of 6,460 Verona Pharma plc (NASDAQ:VRNA)Keybank National Association OH acquired a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,460 shares of the company's stock, valued at approximatelyMarch 11, 2025 | marketbeat.comVerona Pharma management to meet with TruistMarch 7, 2025 | markets.businessinsider.comCandriam S.C.A. Lowers Stake in Verona Pharma plc (NASDAQ:VRNA)Candriam S.C.A. cut its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 43.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 440,313 shares of the company's stock after selling 332,684 sharMarch 7, 2025 | marketbeat.comNew York State Common Retirement Fund Makes New $285,000 Investment in Verona Pharma plc (NASDAQ:VRNA)New York State Common Retirement Fund bought a new stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,143 shares of the company's stock, valued at approximately $285,0March 6, 2025 | marketbeat.comBTIG Sticks to Its Buy Rating for Verona Pharma (VRNA)March 5, 2025 | markets.businessinsider.comVerona Pharma plc (VRNA): A Bull Case TheoryMarch 5, 2025 | insidermonkey.comBeat the Market the Zacks Way: Verona, Visa, Starbucks in FocusMarch 3, 2025 | finance.yahoo.comVerona Pharma management to meet with Piper SandlerMarch 3, 2025 | markets.businessinsider.comHC Wainwright Predicts Verona Pharma Q1 EarningsVerona Pharma plc (NASDAQ:VRNA - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Verona Pharma in a report released on Friday, February 28th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings per shareMarch 3, 2025 | marketbeat.comEarnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsMarch 2, 2025 | finance.yahoo.comVerona Pharma plc (NASDAQ:VRNA) Given Average Rating of "Buy" by AnalystsVerona Pharma plc (NASDAQ:VRNA - Get Free Report) has earned an average recommendation of "Buy" from the seven research firms that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendationMarch 2, 2025 | marketbeat.com Remove Ads Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address VRNA Media Mentions By Week VRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRNA News Sentiment▼1.550.78▲Average Medical News Sentiment VRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRNA Articles This Week▼86▲VRNA Articles Average Week Remove Ads Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News ITCI News GMAB News RDY News MRNA News ASND News QGEN News VTRS News ROIV News LNTH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRNA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts